Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections, 9251-9252 [2012-3625]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices
can also be submitted by email to
DCAS@CDC.GOV.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
John Howard,
Director, National Institute for Occupational
Safety and Health.
Determination Concerning a Petition
To Add a Class of Employees to the
Special Exposure Cohort
[FR Doc. 2012–3645 Filed 2–15–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Designation of a Class of Employees
for Addition to the Special Exposure
Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
HHS gives notice of a
decision to designate a class of
employees from the Linde Ceramics
Plant in Tonawanda, New York, as an
addition to the Special Exposure Cohort
(SEC) under the Energy Employees
Occupational Illness Compensation
Program Act of 2000. On February 2,
2012, the Secretary of HHS designated
the following class of employees as an
addition to the SEC:
SUMMARY:
All Atomic Weapons Employees who
worked in any area at the Linde Ceramics
Plant in Tonawanda, New York, from
November 1, 1947, through December 31,
1953, for a number of work days aggregating
at least 250 work days, occurring either
solely under this employment or in
combination with work days within the
parameters established for one or more other
classes of employees included in the SEC.
This designation will become effective
on March 3, 2012, unless Congress
provides otherwise prior to the effective
date. After this effective date, HHS will
publish a notice in the Federal Register
reporting the addition of this class to the
SEC or the result of any provision by
Congress regarding the decision by HHS
to add the class to the SEC.
srobinson on DSK4SPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
NIOSH, 4676 Columbia Parkway, MS
C–46, Cincinnati, OH 45226, Telephone
1–877–222–7570. Information requests
can also be submitted by email to
DCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2012–3646 Filed 2–15–12; 8:45 am]
BILLING CODE 4163–19–P
VerDate Mar<15>2010
16:31 Feb 15, 2012
Jkt 226001
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
BILLING CODE 4163–19–P
HHS gives notice of a
determination concerning a petition to
add a class of employees from the
Hooker Electrochemical Company in
Niagara Falls, New York, to the Special
Exposure Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000
(EEOICPA), 42 U.S.C. 7384q. On
February 2, 2012, the Secretary of HHS
determined that the following class of
employees does not meet the statutory
criteria for addition to the SEC as
authorized under EEOICPA:
SUMMARY:
All employees who worked in any location
at the Hooker Electrochemical Corporation
during the operational period from January 1,
1943, through December 31, 1948, and during
the residual period from January 1, 1949, to
December 31, 1976.
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone
1–877–222–7570. Information requests
can also be submitted by email to
DCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2012–3644 Filed 2–15–12; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the Secretary’s
Advisory Committee on Human
Research Protections
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health, Office for Human Research
Protections.
ACTION: Notice.
AGENCY:
Authority: 42 U.S.C. 217a, Section 222 of
the Public Health Service Act, as amended.
The Committee is governed by the provisions
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
9251
of Public Law 92–463, as amended (5 U.S.C.
Appendix 2), which sets forth standards for
the formation and use of advisory
committees.
The Office for Human
Research Protections (OHRP), a program
office in the Office of the Assistant
Secretary for Health, Department of
Health and Human Services (HHS),
previously published a notice (76 FR
243, 19 Dec 2011, pp. 78660–78661)
seeking nominations of qualified
candidates to be considered for
appointment as members of the
Secretary’s Advisory Committee on
Human Research Protections (SACHRP).
OHRP would like to announce a four
week extension of the SACHRP
nomination period. As a result of this
extension, the nomination period will
now end at the close of business on
March 16, 2012.
DATES: Nominations for membership on
the Committee must be received no later
than March 16, 2012.
ADDRESSES: Nominations should be
mailed or delivered to Dr. Jerry
Menikoff, Director, Office for Human
Research Protections, Department of
Health and Human Services, 1101
Wootton Parkway, Suite 200, Rockville,
MD 20852. Nominations will not be
accepted by email or by facsimile.
FOR FURTHER INFORMATION CONTACT: Julia
Gorey, Executive Director, SACHRP,
Office for Human Research Protections,
1101 Wootton Parkway, Suite 200,
Rockville, MD 20852, telephone: 240–
453–8141. A copy of the Committee
charter and list of the current members
can be obtained by contacting Ms.
Gorey, accessing the SACHRP Web site
at www.hhs.gov/ohrp/sachrp, or
requesting them via email at
sachrp@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: The
Committee provides advice on matters
pertaining to the continuance and
improvement of functions within the
authority of HHS directed toward
protections for human subjects in
research. Specifically, the Committee
provides advice relating to the
responsible conduct of research
involving human subjects with
particular emphasis on special
populations such as neonates and
children, prisoners, the decisionally
impaired, pregnant women, embryos
and fetuses; individuals and
populations in international studies,
investigator conflicts of interest and
research involving individually
identifiable samples, data or
information.
In addition, the Committee is
responsible for reviewing selected
ongoing work and planned activities of
SUMMARY:
E:\FR\FM\16FEN1.SGM
16FEN1
srobinson on DSK4SPTVN1PROD with NOTICES
9252
Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices
OHRP and other offices or agencies
within HHS responsible for human
subjects protection. These evaluations
may include, but are not limited to, a
review of assurance systems, the
application of minimal research risk
standards, the granting of waivers,
education programs sponsored by
OHRP, and the ongoing monitoring and
oversight of institutional review boards
and the institutions that sponsor
research.
Nominations: OHRP is requesting
nominations to fill four positions for
voting members of SACHRP. Two
positions will become vacant in July
and two in October, 2012. Nominations
of potential candidates for consideration
are being sought from a wide array of
fields, including, but not limited to:
public health and medicine, behavioral
and social sciences, health
administration, and biomedical ethics.
To qualify for consideration of
appointment to the Committee, an
individual must possess demonstrated
experience and expertise in any of the
several disciplines and fields pertinent
to human subjects protection or clinical
research.
The individuals selected for
appointment to the Committee can be
invited to serve a term of up to four
years. Committee members receive a
stipend and reimbursement for per diem
and any travel expenses incurred for
attending Committee meetings or
conducting other business in the
interest of the Committee. Interested
applicants may self-nominate.
Nominations should be typewritten.
The following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity), and a statement
that the nominee is willing to serve as
a member of the Committee; (2) the
nominator’s name, address, daytime
telephone number, and the home or
work address, telephone number, and
email address of the individual being
nominated; and (3) a current copy of the
nominee’s curriculum vitae. Federal
employees should not be nominated for
consideration of appointment to this
Committee.
The Department makes every effort to
ensure that the membership of HHS
Federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made to ensure
that individuals from a broad
representation of geographic areas,
VerDate Mar<15>2010
16:31 Feb 15, 2012
Jkt 226001
women and men, ethnic and minority
groups, and the disabled are given
consideration for membership on HHS
Federal advisory committees.
Appointment to this Committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
Individuals who are selected to be
considered for appointment will be
required to provide detailed information
regarding their financial holdings,
consultancies, and research grants or
contracts. Disclosure of this information
is necessary in order to determine if the
selected candidate is involved in any
activity that may pose a potential
conflict with the official duties to be
performed as a member of SACHRP.
Dated: February 10, 2012.
Jerry Menikoff,
Director, Office for Human Research
Protections Executive Secretary, Secretary’s
Advisory Committee on Human Research
Protections.
[FR Doc. 2012–3625 Filed 2–15–12; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting for Software Developers on
the Technical Specifications for
Common Formats for Patient Safety
Data Collection and Event Reporting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
The Patient Safety and
Quality Improvement Act of 2005, 42
U.S.C. 299b–21 to b–26, (Patient Safety
Act) provides for the formation of
Patient Safety Organizations (PSOs),
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety Act (at 42
U.S.C. 299b–23) authorizes the
collection of this information in a
standardized manner, as explained in
the related Patient Safety and Quality
Improvement Final Rule, 42 CFR part 3
(Patient Safety Rule), published in the
Federal Register on November 21, 2008:
73 FR 70731–70814. AHRQ coordinates
the development of a set of common
definitions and reporting formats
(Common Formats) that allow health
care providers to voluntarily collect and
submit standardized information
regarding patient safety events. In order
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
to support the Common Formats, AHRQ
has provided technical specifications to
promote standardization by ensuring
that data collected by PSOs and other
entities are clinically and electronically
comparable. More information on the
Common Formats, including the
technical specifications, can be obtained
through AHRQ’s PSO Web site: https://
www.PSO.AHRQ.GOV/.
The purpose of this notice is to
announce a meeting to discuss the
Common Formats technical
specifications. This meeting is designed
as an interactive forum where PSOs and
software developers can provide input
on these technical specifications. AHRQ
especially requests input from those
entities which have used AHRQ’s
technical specifications and
implemented, or plan to implement, the
formats electronically.
DATES: The meeting will be held from 10
a.m. to 3:30 p.m. on April 12, 2012.
ADDRESSES: The meeting will be held at
the Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD
20814.
FOR FURTHER INFORMATION CONTACT:
Susan Grinder, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
PSO@AHRQ.HHS.GOV.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Disability Management
at (301) 827–4840, no later than March
28, 2012.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act and Patient
Safety Rule establish a framework by
which doctors, hospitals, skilled
nursing facilities, and other health care
providers may voluntarily report
information regarding patient safety
events and quality of care. Information
that is assembled and developed by
providers for reporting to PSOs and the
information received and analyzed by
PSOs—called ‘‘patient safety work
product’’—is privileged and
confidential. Patient safety work
product is used to identify events,
patterns of care, and unsafe conditions
that increase risks and hazards to
patients. Definitions and other details
about PSOs and patient safety work
product are included in the Patient
Safety Rule.
E:\FR\FM\16FEN1.SGM
16FEN1
]]>Agencies
[Federal Register Volume 77, Number 32 (Thursday, February 16, 2012)]
[Notices]
[Pages 9251-9252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3625]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the Secretary's
Advisory Committee on Human Research Protections
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health, Office for
Human Research Protections.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended. The Committee is governed by the provisions
of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of advisory committees.
SUMMARY: The Office for Human Research Protections (OHRP), a program
office in the Office of the Assistant Secretary for Health, Department
of Health and Human Services (HHS), previously published a notice (76
FR 243, 19 Dec 2011, pp. 78660-78661) seeking nominations of qualified
candidates to be considered for appointment as members of the
Secretary's Advisory Committee on Human Research Protections (SACHRP).
OHRP would like to announce a four week extension of the SACHRP
nomination period. As a result of this extension, the nomination period
will now end at the close of business on March 16, 2012.
DATES: Nominations for membership on the Committee must be received no
later than March 16, 2012.
ADDRESSES: Nominations should be mailed or delivered to Dr. Jerry
Menikoff, Director, Office for Human Research Protections, Department
of Health and Human Services, 1101 Wootton Parkway, Suite 200,
Rockville, MD 20852. Nominations will not be accepted by email or by
facsimile.
FOR FURTHER INFORMATION CONTACT: Julia Gorey, Executive Director,
SACHRP, Office for Human Research Protections, 1101 Wootton Parkway,
Suite 200, Rockville, MD 20852, telephone: 240-453-8141. A copy of the
Committee charter and list of the current members can be obtained by
contacting Ms. Gorey, accessing the SACHRP Web site at www.hhs.gov/ohrp/sachrp, or requesting them via email at sachrp@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: The Committee provides advice on matters
pertaining to the continuance and improvement of functions within the
authority of HHS directed toward protections for human subjects in
research. Specifically, the Committee provides advice relating to the
responsible conduct of research involving human subjects with
particular emphasis on special populations such as neonates and
children, prisoners, the decisionally impaired, pregnant women, embryos
and fetuses; individuals and populations in international studies,
investigator conflicts of interest and research involving individually
identifiable samples, data or information.
In addition, the Committee is responsible for reviewing selected
ongoing work and planned activities of
[[Page 9252]]
OHRP and other offices or agencies within HHS responsible for human
subjects protection. These evaluations may include, but are not limited
to, a review of assurance systems, the application of minimal research
risk standards, the granting of waivers, education programs sponsored
by OHRP, and the ongoing monitoring and oversight of institutional
review boards and the institutions that sponsor research.
Nominations: OHRP is requesting nominations to fill four positions
for voting members of SACHRP. Two positions will become vacant in July
and two in October, 2012. Nominations of potential candidates for
consideration are being sought from a wide array of fields, including,
but not limited to: public health and medicine, behavioral and social
sciences, health administration, and biomedical ethics. To qualify for
consideration of appointment to the Committee, an individual must
possess demonstrated experience and expertise in any of the several
disciplines and fields pertinent to human subjects protection or
clinical research.
The individuals selected for appointment to the Committee can be
invited to serve a term of up to four years. Committee members receive
a stipend and reimbursement for per diem and any travel expenses
incurred for attending Committee meetings or conducting other business
in the interest of the Committee. Interested applicants may self-
nominate.
Nominations should be typewritten. The following information should
be included in the package of material submitted for each individual
being nominated for consideration: (1) A letter of nomination that
clearly states the name and affiliation of the nominee, the basis for
the nomination (i.e., specific attributes which qualify the nominee for
service in this capacity), and a statement that the nominee is willing
to serve as a member of the Committee; (2) the nominator's name,
address, daytime telephone number, and the home or work address,
telephone number, and email address of the individual being nominated;
and (3) a current copy of the nominee's curriculum vitae. Federal
employees should not be nominated for consideration of appointment to
this Committee.
The Department makes every effort to ensure that the membership of
HHS Federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
to ensure that individuals from a broad representation of geographic
areas, women and men, ethnic and minority groups, and the disabled are
given consideration for membership on HHS Federal advisory committees.
Appointment to this Committee shall be made without discrimination on
the basis of age, race, ethnicity, gender, sexual orientation,
disability, and cultural, religious, or socioeconomic status.
Individuals who are selected to be considered for appointment will
be required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is necessary in order to determine if the selected
candidate is involved in any activity that may pose a potential
conflict with the official duties to be performed as a member of
SACHRP.
Dated: February 10, 2012.
Jerry Menikoff,
Director, Office for Human Research Protections Executive Secretary,
Secretary's Advisory Committee on Human Research Protections.
[FR Doc. 2012-3625 Filed 2-15-12; 8:45 am]
BILLING CODE 4150-36-P
